Santos-Oliveira R - Search Results

1

Santos-Oliveira R. Santos-Oliveira R. Rev Salud Publica (Bogota). 2008 Jun-Jul;10(3):477-87. doi: 10.1590/s0124-00642008000300013. Rev Salud Publica (Bogota). 2008. PMID: 19043639 Review.

2

Development, characterization, and anti-leishmanial activity of topical amphotericin B nanoemulsions.

Dos Santos Matos AP, Lopes DCDXP, Peixoto MLH, da Silva Cardoso V, Vermelho AB, Santos-Oliveira R, Viçosa AL, Holandino C, Ricci-Júnior E. Dos Santos Matos AP, et al. Among authors: santos oliveira r. Drug Deliv Transl Res. 2020 Dec;10(6):1552-1570. doi: 10.1007/s13346-020-00821-5. Drug Deliv Transl Res. 2020. PMID: 32676952

3

The Effect of Nanosystems on ATP-Binding Cassette Transporters: Understanding the Influence of Nanosystems on Multidrug Resistance Protein-1 and P-glycoprotein.

Mello FVC, de Moraes GN, Maia RC, Kyeremateng J, Iram SH, Santos-Oliveira R. Mello FVC, et al. Int J Mol Sci. 2020 Apr 10;21(7):2630. doi: 10.3390/ijms21072630. Int J Mol Sci. 2020. PMID: 32290047 Free PMC article.

4

Trends in Nanotechnology for in vivo Cancer Diagnosis: Products and Patents.

do Nascimento T, Tavares M, Monteiro MSSB, Santos-Oliveira R, Todeschini AR, de Souza VT, Ricci-Júnior E. do Nascimento T, et al. Curr Pharm Des. 2020;26(18):2167-2181. doi: 10.2174/1381612826666200219094853. Curr Pharm Des. 2020. PMID: 32072890 Review.

5

Radiopharmaceuticals drug interactions: a critical review.

Santos-Oliveira R, Smith SW, Carneiro-Leão AM. Santos-Oliveira R, et al. An Acad Bras Cienc. 2008 Dec;80(4):665-75. doi: 10.1590/s0001-37652008000400008. An Acad Bras Cienc. 2008. PMID: 19039490 Review.

6

Undesirable events with radiopharmaceuticals.

Santos-Oliveira R. Santos-Oliveira R. Tohoku J Exp Med. 2009 Apr;217(4):251-7. doi: 10.1620/tjem.217.251. Tohoku J Exp Med. 2009. PMID: 19346729 Review.

7

Comparison of Limulus amebocyte lysates with the United States pharmacopeial pyrogen test and the portable test system for radiopharmaceuticals.

Santos-Oliveira R. Santos-Oliveira R. J AOAC Int. 2010 Sep-Oct;93(5):1458-61. J AOAC Int. 2010. PMID: 21140657

8

Pitfalls with radiopharmaceuticals.

Santos-Oliveira R, Machado M. Santos-Oliveira R, et al. Am J Med Sci. 2011 Jul;342(1):50-3. doi: 10.1097/MAJ.0b013e318216ee86. Am J Med Sci. 2011. PMID: 21642816 Review.

9

Radiopharmaceutical research and production in Brazil: a 30-year history of participation in the nuclear medicine scenario.

Santos-Oliveira R, Antunes LJ. Santos-Oliveira R, et al. J Nucl Med Technol. 2011 Sep;39(3):237-9. doi: 10.2967/jnmt.111.088450. Epub 2011 Jul 27. J Nucl Med Technol. 2011. PMID: 21795367

10

Polymeric nanoparticles of FMISO: are nano-radiopharmaceuticals better than conventional ones?

de Souza Albernaz M, de Carvalho Patricio BF, Weissmuller G, Reynaud F, Adamsen TCh, Santos-Oliveira R. de Souza Albernaz M, et al. Curr Radiopharm. 2012 Oct;5(4):336-9. doi: 10.2174/1874471011205040336. Curr Radiopharm. 2012. PMID: 22724424

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results